Skip to main content

Ortivus AB (publ) quarterly report for the period July – September 2020

2020-11-10 08:30

Ortivus’ customer deliveries continue at a high pace despite Covid-19

Highlights July – Sep 2020

  • Hardware delivery of 12.0 MSEK to South Central Ambulance Service performed
  • Important milestone passed for the delivery project in Singapore
  • Ortivus and SCHILLER AG signed a distribution agreement for the Nordic market

Highlights post-period end

  • Ortivus begins the process of moving operations, such as production and reparations of MobiMed monitoring equipment, in-house.

July – Sep 2020

  • Net sales amounted to 25.4 (10.4) MSEK, which is an increase in sales of 144%
  • Operating profit cleared for comparative distortion items amounted to 1.2 (-0.8) MSEK. Operating profit, including comparative distortion items, amounted to 1.2 (-3.3) MSEK
  • EBITDA cleared for comparative distortion items, amounted to 2.0 (1.0) MSEK. EBITDA including comparative distortion items, amounted to 2.0 (-1.6) MSEK
  • Profit after tax was 1.2 (-3.3) MSEK
  • Earnings per share after tax and before and after dilution amounted to 0.03 (-0.09) SEK

Jan – Sep 2020

  • Net sales amounted to 85.2 (33.7) MSEK, which is an increase in sales of 154%
  • Operating profit cleared for comparative distortion items, amounted to 9.2 (-8.5) MSEK. Operating profit including comparative distortion items, amounted to 9.2 (-13.7) MSEK
  • EBITDA cleared for comparative distortion items, amounted to 11.4 (-3.5) MSEK. EBITDA including comparative distortion items, amounted to 11.4 (-8.7) MSEK
  • Profit after tax was 9.1 (-14.2) MSEK
  • Earnings per share after tax and before and after dilution, amounted to 0.21 (-0.42) SEK
Amount in KSEK Jul-Sep 2020 Jul-Sep 2019 Jan-Sep 2020 Jan-Sep 2019 Jan-Dec 2019
Net sales 25 351 10 407 85 719 33 747 50 848
Gross margin, % 31% 28% 33% 37% 41%
Operating profit,
excl. comparative distortion items
1 229 -757 9 225 -8 466 -10 197
Operating margin, %
excl. comparative distortion items
5% -7% 11% -25% -20%
EBITDA,
excl. comparative distortion items
2 024 1 018 11 437 -3 471 -3 271

Get in touch

Empower your team with smarter tools

Discover why leading healthcare organisations are choosing Ortivus.

Get contacted

Fill in the form and one of our sales representatives will contact you as soon as possible.

Required